OROS MPH

DRUG2 trials

Sponsors

Ortho-McNeil Janssen Scientific Affairs, LLC, Peking University

Conditions

Attention Deficit Disorder With HyperactivityAttention Deficit Hyperactivity Disorder

Phase 4

Adult Study / OROS Methylphenidate Hydrochloride (HCL) (OROS MPH) in Adults With Attention Deficit Hyperactivity Disorder (ADHD)

CompletedNCT00937040

Ortho-McNeil Janssen Scientific Affairs, LLCAttention Deficit Disorder With Hyperactivity

Start: 2009-07-31End: 2010-02-28Updated: 2013-07-30

Concerta and Strattera on the Executive Function in Attention Deficit Hyperactivity Disorder (ADHD) Children

CompletedNCT01065259

Peking UniversityAttention Deficit Hyperactivity Disorder

Start: 2008-04-30End: 2010-12-31Updated: 2011-07-22

Related Papers

Assessment of centanafadine in adults with ADHD: a matching adjusted indirect comparison versus methylphenidate hydrochloride extended release (Concerta).

2024-07-103 citations

Randomized, 6-Week, Placebo-Controlled Study of Treatment for Adult Attention-Deficit/Hyperactivity Disorder

The Journal of Clinical Psychiatry2016-07-2931 citations

Osmotic Release Oral System Methylphenidate Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder in Chinese Youth: 8-Week Comparative Efficacy and 1-Year Follow-Up

Journal of Child and Adolescent Psychopharmacology2016-01-1816 citations